These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10815933)

  • 41. Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects.
    Pogorzelska A; Żołnowska B; Bartoszewski R
    Biochimie; 2018 Aug; 151():85-106. PubMed ID: 29870804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of new specific inhibitors for cathepsins and its application for medical field].
    Katunuma N; Tsuge H; Asao T
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1057-64. PubMed ID: 10771673
    [No Abstract]   [Full Text] [Related]  

  • 43. Cathepsin K inhibition-induced mitochondrial ROS enhances sensitivity of cancer cells to anti-cancer drugs through USP27x-mediated Bim protein stabilization.
    Seo SU; Woo SM; Kim MW; Lee HS; Kim SH; Kang SC; Lee EW; Min KJ; Kwon TK
    Redox Biol; 2020 Feb; 30():101422. PubMed ID: 31901727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.
    Löser R; Pietzsch J
    Front Chem; 2015; 3():37. PubMed ID: 26157794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of cell death in neuroblastoma by inhibition of cathepsins B and L.
    Colella R; Lu G; Glazewski L; Korant B; Matlapudi A; England MR; Craft C; Frantz CN; Mason RW
    Cancer Lett; 2010 Aug; 294(2):195-203. PubMed ID: 20362389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
    Gole B; Durán Alonso MB; Dolenc V; Lah T
    Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calpain regulates neutrophil chemotaxis.
    Lokuta MA; Nuzzi PA; Huttenlocher A
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4006-11. PubMed ID: 12649322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
    Johansson AC; Norberg-Spaak L; Roberg K
    Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ; Ng LT; Lin CC
    Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S; Yu R; Tan TH; Kong AN
    Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells.
    Zhu DM; Uckun FM
    Clin Cancer Res; 2000 May; 6(5):2064-9. PubMed ID: 10815933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cysteine cathepsin proteases as pharmacological targets in cancer.
    Palermo C; Joyce JA
    Trends Pharmacol Sci; 2008 Jan; 29(1):22-8. PubMed ID: 18037508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cathepsins and pancreatic cancer: the 2012 update.
    Sulpizio S; Franceschini N; Piattelli A; Di Sebastiano P; Innocenti P; Selvaggi F
    Pancreatology; 2012; 12(5):395-401. PubMed ID: 23127526
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.